Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancer

Pillay, 2005, The use of fingernails as a means of assessing bone health: a pilot study, J Womens Health (Larchmt), 14, 339, 10.1089/jwh.2005.14.339 Towler, 2007, Raman spectroscopy of the human nail: a potential tool for evaluating bone health?, J Mater Sci Mater Med, 18, 759, 10.1007/s10856-006-0018-9 Moran, 2007, Preliminary work on the development of a novel detection method for osteoporosis, J Mater Sci Mater Med, 18, 969, 10.1007/s10856-006-0037-6 Eastell, 2006, ATAC Trialists' Group Effect of an aromatase inhibitor on BMD and bone turnover markers: 2-year results of the anastrozole, tamoxifen, alone or in combination (ATAC) trial (18233230), J Bone Miner Res, 21, 1215, 10.1359/jbmr.060508 Geisler, 2006, Changes in bone and lipid metabolism in postmenopausal women with early breast cancer after terminating 2-year treatment with exemestane: a randomised, placebo-controlled study, Eur J Cancer, 42, 2968, 10.1016/j.ejca.2006.07.005 Ding, 2007, Bone health in postmenopausal women with early breast cancer: how protective is tamoxifen?, Cancer Treat Rev, 33, 506, 10.1016/j.ctrv.2007.04.005 Powles, 1996, Effect of tamoxifen on bone mineral density measured by dual-energy X-ray absorptiometry in healthy premenopausal and postmenopausal women, J Clin Oncol, 14, 78, 10.1200/JCO.1996.14.1.78 Coates, 2007, Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98, J Clin Oncol, 25, 486, 10.1200/JCO.2006.08.8617 BIG 1-98 Collaborative Group, 2005, A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, N Engl J Med, 353, 2747, 10.1056/NEJMoa052258 Buzdar, 2001, Phase III, multicenter, double-blind, randomized study of letrozole, an aromatase inhibitor, for advanced breast cancer versus megestrol acetate, J Clin Oncol, 19, 3357, 10.1200/JCO.2001.19.14.3357 Bean, 1980, Nail growth. Thirty-five years of observation, Arch Intern Med, 140, 73, 10.1001/archinte.1980.00330130075019 Brufsky, 2008, Z-FAST and ZO-FAST Study Groups Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole, Oncologist, 13, 503, 10.1634/theoncologist.2007-0206 Gnant, 2008, Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-response, stage I and II breast cancer: first efficacy results from ABCSG-12, J Clin Oncol, 26, 15S, 10.1200/jco.2008.26.15_suppl.lba4 Lipton, 2007, Randomized active-controlled phase II study of denosumab efficacy and safety in patients with breast cancer-related bone metastases, J Clin Oncol, 25, 4431, 10.1200/JCO.2007.11.8604